|
(b)(4).The device was not returned for evaluation.The reported patient effect of myocardial infarction is listed in the xience alpine everolimus eluting coronary stent systems instructions for use as a known patient effect of coronary stenting procedures.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.A conclusive cause for the reported patient effect, and the relationship to the product, if any, cannot be determined.There is no indication of a product quality issue with respect to manufacture, design or labeling.
|
|
It was reported that a 3.50 x 18 mm xience alpine stent was implanted on (b)(6) 2017.On (b)(6) 2017 the patient was re-admitted with cardiovascular symptoms including myocardial infarction.Although the treatment performed is unspecified, the fact that hospitalization occurred, indicates that some form of treatment was performed.The final patient outcome is unknown.No additional information was provided.
|